Haleon (NYSE:HLN) Sees Large Volume Increase – What’s Next?

Posted by Brian Himes on Jul 31st, 2026

Haleon PLC Sponsored ADR (NYSE:HLN – Get Free Report) shares saw unusually-strong trading volume on Wednesday . 12,725,629 shares were traded during mid-day trading, an increase of 43% from the previous session’s volume of 8,882,040 shares.The stock last traded at $10.1450 and had previously closed at $10.27.

Wall Street Analysts Forecast Growth

HLN has been the subject of several analyst reports. Wall Street Zen upgraded Haleon from a “hold” rating to a “buy” rating in a research report on Sunday, July 12th. Zacks Research cut Haleon from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 21st. Rothschild & Co Redburn downgraded Haleon from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 16th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research report on Tuesday, June 30th. Finally, Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Haleon in a research note on Thursday, April 30th. Two investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy”.

Read Our Latest Research Report on HLN

Haleon Price Performance

The business’s 50-day simple moving average is $9.43 and its 200 day simple moving average is $9.85. The company has a market capitalization of $44.51 billion, a P/E ratio of 25.91, a P/E/G ratio of 2.38 and a beta of 0.13. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 0.47.

Haleon Cuts Dividend

The company also recently announced a dividend, which will be paid on Thursday, September 17th. Investors of record on Friday, August 14th will be issued a dividend of $0.0642 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a yield of 127.0%. Haleon’s payout ratio is presently 64.10%.

Institutional Investors Weigh In On Haleon

A number of institutional investors have recently added to or reduced their stakes in the company. Western Wealth Management LLC acquired a new position in shares of Haleon during the 1st quarter valued at $29,000. Parkside Financial Bank & Trust raised its stake in shares of Haleon by 101.3% in the 4th quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock worth $29,000 after buying an additional 1,433 shares in the last quarter. Annis Gardner Whiting Capital Advisors LLC lifted its holdings in shares of Haleon by 402.0% in the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 3,002 shares of the company’s stock valued at $30,000 after buying an additional 2,404 shares during the period. Geneos Wealth Management Inc. lifted its holdings in shares of Haleon by 33.0% in the first quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock valued at $50,000 after buying an additional 1,203 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Haleon by 428.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 6,321 shares of the company’s stock valued at $57,000 after buying an additional 5,124 shares in the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

About Haleon

(Get Free Report)

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.